Navigation Links
Studies Show Combination Drugs As A Poor Substitute For Anti-Coagulants In Stroke

A new study has broken the hopes that a combination of aspirin and another clot-preventing drug might be a better alternative for preventing strokes //in people with the abnormal heart rhythm called as ‘atrial fibrillation’ than the standard therapy, of warfarin.

Canadian researchers have cut short their study after the preliminary results showed that there is a higher incidence of not only of strokes, but also of minor bleeding episodes, in people taking the combination of aspirin and clopidogrel (Plavix), They reported their findings in a report in the June 10 issue of The Lancet.

It was explained that warfarin, an anticoagulant, is effective for preventing clotting and strokes in patients, but is was very hard to manage. Dr. Stuart Connelly, director of the division of cardiology at McMaster University, in Hamilton, Ontario, the study leader said that this trial does not create any new indications for clopidogrel, he explained that atrial fibrillation might cause blood to pool in the heart, that could encourage the formation of clots that can then travel to the brain to cause stroke.

Even though warfarin is a powerful anti-clotting agent the doctors world over have always tried to find and use an alternative. The patients using warfarin had to take frequent blood tests to make sure that the dosage is precisely right, due to the high risk of major bleeding episodes is always present. It was explained that the management of the treatment with warfarin is very difficult.

Dr. Anthony J. Furlan, head of the section of stroke and neurological intensive care at the Cleveland Clinic stated that studies have shown that this is the reason as to why only 50% of the patients with atrial fibrillation were on warfarin therapy. Furlan further stated that due to its risks, doctors typically hesitate to prescribe warfarin to very elderly patients, those prone to falls that might precipitate a bleeding episode and those who are unlik ely to follow the strict monitoring regimen.

Dr Furlan also said that the study but confirms that the treatment of choice in the vast majority of patients with atrial fibrillation is warfarin. The study was conducted by comparing more than 6,700 people with atrial fibrillation who took either the standard dose of warfarin or a combination of 75 milligrams of clopidogrel and 75 milligrams to 100 milligrams of aspirin a day. It was found that those taking the combination treatment had a 44 percent higher incidence of stroke and a slightly lower incidence of major bleeding episodes than people taking warfarin.

Both the doctors, Furlan and Connolly said they are now prescribing aspirin for people with atrial fibrillation for those who are not suitable for warfarin treatment. But Connolly explained that this could change, he said that another section of the trail that is still being conducted is comparing the combination of clopidogrel plus aspirin to aspirin alone. Stating that the results are expected by the middle of 2008, he said that there is still no clue as to how the results might develop. Connolly while stating that he believes that the combination will prove to be better than aspirin alone he said that it is his hope and expectation.

'"/>




Related medicine news :

1. Studies On Hearing Loss Discovers New Causes
2. Broccoli Found to Block Cancer Progression In Both Animal and Human Studies
3. Cure For Autism Could Be Established Through Hamster Studies
4. Despite More Studies Researchers Are Still Confound With ADHD
5. Studies Show Brain becomes Less Specialized With Age
6. ISB To Establish Research Chair On Real Estate And Urban Studies
7. Further Studies Needed To Completely Understand About Ventricular Fibrillation
8. Studies Report Mammograms Unsafe
9. Six Indians Win Australian Studies Fellowships
10. Circumcision Studies to Continue Says Health Panel
11. Epidemic Studies Call For A Ban In Sales Of Fresh Chicken In New Zealand
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: An Australian ... account of his paramedic experiences. Schanssema describes the tragedies he saw, as well as ... overcome them. , Schanssema, initially unsure of the career path he wanted to take, ...
(Date:2/24/2017)... ... , ... The International Association of Eating Disorders Professionals (iaedp) announces the 2017 ... image mannequin art competition. Selected from 15 submissions from around the nation, the top ... 31st annual iaedp Symposium, March 22 – 26 in Las Vegas. , This year, ...
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations ... International Elite division on February 12th. Ms. Esparza qualified into this prestigious ... qualifier competition held in Las Vegas, Nevada. Frida is one of approximately 25 ...
(Date:2/23/2017)... ... February 23, 2017 , ... The 89th Academy Awards will be celebrated ... National Education Policy Center Bunkum Award. We invite you to enjoy our 11th annual ... Bunkum winner is the Center for American Progress (CAP), for its report, Lessons From ...
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, ... June: From Not to Hot,” which will begin airing on February 24, 2017. The ... millions from the 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Urinary Incontinence Drugs Price Analysis ... the global Urinary Incontinence market. The research answers the following ... marketed for Urinary Incontinence and their clinical attributes? How are they ...
(Date:2/23/2017)... Feb. 23, 2017  Genesis Healthcare Services has merged ... was made by Bill Monast , President and ... and Nathan Feltman , executives with Home Health ... LLC. This acquisition helps Hospice Cloud ... technology enabled durable medical equipment (DME) solutions for the ...
(Date:2/23/2017)... ITL Limited, ( ASX: ITD ), an innovative diversified healthcare company, ... 31 December 2016 compared with the previous corresponding period. A full ... here . Highlights Profit ... Earnings per share of 2.2 cents (Dec 2015: 1.2 cents; ... up 11%) Profit before tax of $2.12m (Dec ...
Breaking Medicine Technology: